Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance

PURPOSE: Approximately 15% to 20% of our patients with head and neck cancer receiving neoadjuvant chemotherapy (NACT) discontinue therapy because of various nonmedical reasons. We sought to analyze the factors associated with treatment default and noncompliance among these patients. PATIENTS AND MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Glob Oncol
Main Authors: Patil, Vijay M., Noronha, Vanita, Joshi, Amit, Muddu, Vamshi, Dhumal, Sachin, Bhattacharjee, Atanu, Prabhash, Kumar
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5539870/
https://ncbi.nlm.nih.gov/pubmed/28804775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.2015.000265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados